Philippe Jacqmin

55 papers receiving 1.5k citations

Philippe Jacqmin's Hit Papers

Efficacy and safety of emapalumab in macrophage activation syndrome 2023 · 79 citations
790+2+4Years since publication100200300

Peers

Philippe Jacqmin
Comparison fields: 5 of 112
  • Hematology 402
  • Immunology 345
  • Infectious Diseases 274
  • Virology 55
  • Statistics and Probability 92
Replace Tzy‐Jyun Yao with:
Tzy‐Jyun Yao United States
Christiane Rordorf Switzerland
Nicolas von Ahsen Germany
B D Kahan United States
Margaret K. Vandervoort Canada
Cyril Mamotte Australia
Ronald Gieschke Switzerland
Daniel F. Carr United Kingdom
Young‐A Heo New Zealand
Anthony A. Killeen United States
Philippe Jacqmin relative to Tzy‐Jyun Yao United States Tzy‐Jyun Yao's profile →
Citations per field
00.5×3.0×
Tzy‐Jyun Yao · 1×
Citations per year

Countries citing papers authored by Philippe Jacqmin

Since Specialization
Citations

This map shows the geographic impact of Philippe Jacqmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Jacqmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Jacqmin more than expected).

Fields of papers citing papers by Philippe Jacqmin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Jacqmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Jacqmin. The network helps show where Philippe Jacqmin may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Jacqmin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Jacqmin Line = papers co-authored together Philippe Jacqmin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
Hit paper breakdown →
2020325
2 2006142
3 199892
4 201089
5
Efficacy and safety of emapalumab in macrophage activation syndrome
Hit paper breakdown →
202379
6 200473
7 201668
8 201063
9 201958
10 200850
11 201350
12 200750
13 200735
14 200534
15 200827
16 198727
17 201226
18 202123
19 201923
20 201720

About Philippe Jacqmin

Philippe Jacqmin is a scholar working on Hematology, Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Infectious Diseases and Oncology, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Neonatal Health and Biochemistry (4 papers), Epilepsy research and treatment (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), HIV/AIDS drug development and treatment (4 papers), Bone health and osteoporosis research (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (402 citations), Immunology (345 citations), Infectious Diseases (274 citations), Virology (55 citations) and Statistics and Probability (92 citations). Philippe Jacqmin has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Eric Snoeck, Cristina de Min, Ronald Gieschke, Jean‐Louis Steimer, G Lapeyre, Armel Stockis, Maria Ballabio, Alexei A. Grom, Fabrizio De Benedetti and Marc Lavielle. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Pharmacokinetics and Pharmacodynamics, Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and CPT Pharmacometrics & Systems Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact